Cargando…

A Practical Way to Reduce Healthcare Costs in Patients With Heart Failure: Outpatient IV Diuretics Therapy

Detalles Bibliográficos
Autor principal:	Jung, Mi-Hyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Heart Failure 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383340/ https://www.ncbi.nlm.nih.gov/pubmed/36262193 http://dx.doi.org/10.36628/ijhf.2022.0004

Ejemplares similares

Impact of Outpatient Diuretic Infusion Therapy on Healthcare Cost and Readmissions
por: Nair, Nandini, et al.
Publicado: (2022)

Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients
por: Kim, Soo-Jin, et al.
Publicado: (2022)

The Efficacy, Safety, And Cost Savings Of High Dose IV Diuretics For Heart Failure Patients In An Outpatient Setting With Limited Hospital Bed Space Due To Covid-19
por: Lau, Sirimas, et al.
Publicado: (2023)

Diuretic Resistance in Heart Failure
por: Gupta, Richa, et al.
Publicado: (2019)

Innovation in Diuretic Therapy: The Missing Ingredient for Treating Worsening Heart Failure Outside the Hospital?
por: Greene, Stephen J., et al.
Publicado: (2018)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

Diuretics as pathogenetic treatment for heart failure
por: Guglin, Maya
Publicado: (2011)

Optimal diuretic strategies in heart failure
por: Suri, Sarabjeet S., et al.
Publicado: (2021)

Diuretic Resistance Associated With Heart Failure
por: Shams, Elham, et al.
Publicado: (2022)

Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature
por: Wierda, Eric, et al.
Publicado: (2020)

The use of diuretics in heart failure with congestion: we can't judge a book by its cover
por: Palazzuoli, Alberto, et al.
Publicado: (2019)

Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016)

Combined aquaretic and diuretic therapy in acute heart failure
por: Goyfman, Michael, et al.
Publicado: (2017)

Role of Diuretics and Ultrafiltration in Congestive Heart Failure
por: Shchekochikhin, Dmitry, et al.
Publicado: (2013)

The Diuretic Effect of Theocalcin in Congestive Heart Failure
Publicado: (1931)

The Role of Outpatient Intravenous Diuretic Therapy in a Transitional Care Program for Patients With Heart Failure: A Case Series
por: Lazkani, Mohamad, et al.
Publicado: (2012)

The independent association between altered renal arterial resistance and loop diuretic dose in chronic heart failure outpatients
por: Iacoviello, Massimo, et al.
Publicado: (2015)

Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
por: Jackson, Alice M., et al.
Publicado: (2020)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
por: Kristjánsdóttir, Ingibjörg, et al.
Publicado: (2020)

Diuretics in the management of chronic heart failure: when and how
por: Magdy, Joseph S, et al.
Publicado: (2022)

The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure
por: Pethő, Ákos Géza, et al.
Publicado: (2023)

Honey Bees as Diuretic
por: Beers, M. B.
Publicado: (1858)

Iron i.v. in heart failure: ready for implementation?
por: Rocca, Hans-Peter Brunner-La, et al.
Publicado: (2015)

Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2‐year experience
por: Wierda, Eric, et al.
Publicado: (2022)

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
por: Chatur, Safia, et al.
Publicado: (2023)

One‐Year Mortality After Intensification of Outpatient Diuretic Therapy
por: Madelaire, Christian, et al.
Publicado: (2020)

Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome
por: Qavi, Ahmed Hassaan, et al.
Publicado: (2015)

Toward quantification of loop diuretic responsiveness for congestive heart failure
por: Oyama, Mark A., et al.
Publicado: (2022)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
por: Chopra, V. K, et al.
Publicado: (2023)

Diuretin and Diuretics—Practical
por: Richardson, Benjamin Ward
Publicado: (1894)

Empagliflozin: Not just a glorified diuretic
por: John, Mathew
Publicado: (2016)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Markers of diuretic resistance in emergency department patients with acute heart failure
por: Doering, Andrew, et al.
Publicado: (2017)

Worsening renal function in acute heart failure in the context of diuretic response
por: Emmens, Johanna E., et al.
Publicado: (2021)

Use of loop diuretics in patients with chronic heart failure: an observational overview
por: Scholte, Niels TB, et al.
Publicado: (2023)

Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study
por: Imiela, Tomasz, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8au1q37hk8uf6ogc1ctlutsfms